Overview

A Survey Collecting Data on Adult Height in Patients With Achondroplasia Treated With Somatropin

Status:
Completed
Trial end date:
2015-12-04
Target enrollment:
0
Participant gender:
All
Summary
This study is conducted in Japan. The aim of the study is to evaluate the efficacy of somatropin (Norditropin®) on adult height (cm) in patients with achondroplasia / hypochondroplasia enrolled in the GH-1941 study (NCT01516229).
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Novo Nordisk A/S
Criteria
Inclusion Criteria:

- Patients who were enrolled in the GH-1941 study (1997 to 2006) and expected to
theoretically reach the adult height within the study period